Valuation: Celularity Inc.

Market Cap 19.77M 17.16M 16.06M 14.7M 27.74M 1.88B 28.11M 188M 73.76M 941M 74.23M 72.62M 3.13B P/E 2024
-0.79x
P/E 2025 -0.31x
Enterprise Value 88.31M 76.63M 71.76M 65.64M 124M 8.41B 126M 839M 329M 4.2B 332M 324M 13.99B EV / Sales 2024
2.12x
EV / Sales 2025 3.77x
Free-Float
62.82%
Yield 2024 *
-
Yield 2025 -
1 day-6.97%
1 week+0.44%
Current month+7.51%
1 month-14.62%
3 months-26.56%
6 months-47.46%
Current year-38.47%
1 week 0.64
Extreme 0.64
0.78
1 month 0.6
Extreme 0.601
0.84
Current year 0.56
Extreme 0.5601
1.51
1 year 0.56
Extreme 0.5601
4.31
3 years 0.56
Extreme 0.5601
7.97
5 years 0.56
Extreme 0.5601
131.86
10 years 0.56
Extreme 0.5601
134
Manager TitleAgeSince
Chief Executive Officer 66 01/01/2016
Director of Finance/CFO 67 27/02/2026
Compliance Officer 42 01/07/2021
Director TitleAgeSince
Chairman 66 01/01/2016
Director/Board Member 64 01/07/2017
Director/Board Member 73 03/06/2022
Date Insider Type Main position Quantity % Market Cap.
1/12/26 A Free

Director

19,231 0.0667%
1/12/26 A Free

Director

30,000 0.1040%
1/12/26 A Free

Director

19,231 0.0667%
Change 5-day change 1-year change 3-year change Capi.($)
-6.97%+0.44%-78.79%-81.14% 19.77M
+0.46%+4.57%+39.09%+0.74% 77.1B
-1.83%+3.69%+23.09%+182.81% 49.43B
+1.54%-0.85%-4.49%+23.71% 49.27B
-0.31%+7.24%-50.30%-49.66% 44.59B
-0.17%-0.79%+59.49%-23.29% 30.48B
-1.19%-3.75%+52.45%+86.04% 24B
-4.26%-7.01%+101.65%-50.22% 21.5B
+1.65%+6.40%+0.93%+217.56% 20.18B
+1.13%-5.67%+65.36%+120.47% 16.29B
Average -1.02%+0.21%+20.85%+42.70% 33.29B
Weighted average by Cap. -0.21%+0.87%+24.12%+44.08%

Financials

2024 2025
Net sales 54.22M 47.05M 44.06M 40.3M 76.09M 5.16B 77.08M 515M 202M 2.58B 204M 199M 8.59B 26.55M 23.04M 21.57M 19.74M 37.26M 2.53B 37.74M 252M 99.05M 1.26B 99.68M 97.52M 4.21B
Net income -57.89M -50.24M -47.04M -43.03M -81.24M -5.51B -82.3M -550M -216M -2.76B -217M -213M -9.17B -91.72M -79.59M -74.53M -68.17M -129M -8.74B -130M -872M -342M -4.37B -344M -337M -14.53B
Net Debt 68.1M 59.1M 55.34M 50.62M 95.56M 6.49B 96.81M 647M 254M 3.24B 256M 250M 10.79B 68.54M 59.48M 55.69M 50.95M 96.18M 6.53B 97.43M 652M 256M 3.26B 257M 252M 10.86B
Logo Celularity Inc.
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. Its IMPACT manufacturing platform is a fully integrated process designed to optimize the speed of the sourcing of placentas from full-term healthy informed consent donors through the use of proprietary processing methods, cell selection, product-specific chemistry, manufacturing and control (CMC), advanced cell manufacturing and cryopreservation. It also provides contract manufacturing and development services to third parties.
Employees
115
Date Price Change Volume
06/08/26 $0.6830 -6.97% 25,838
05/08/26 $0.7342 +4.38% 10,292
04/08/26 $0.7034 +6.54% 77,815
03/08/26 $0.6602 +3.92% 34,469
31/07/26 $0.6353 -6.57% 80,001

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CELU Stock